Bioentre, LLC

Lyra Therapeutics is a clinical-stage biotechnology company based in Watertown, MA, focused on developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). With a commitment to addressing the needs of the 14 million individuals in the United States suffering from this debilitating condition, Lyra aims to provide long-lasting treatment options that break the cycle of relentless medical management. The company's lead product candidate, LYR210, features a bioabsorbable nasal mesh designed to deliver continuous anti-inflammatory medication directly to the sinonasal tissues for up to six months. By integrating advanced materials science with proven medication, Lyra Therapeutics is poised to transform the treatment landscape for CRS patients, offering a new solution for an often overlooked community. Generated from the website

Takeda Pharmaceuticals USA, based in Cambridge, MA, is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. With a focus on research and development, Takeda strives to transform lives through innovative medicines in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, plasma-derived therapies, and vaccines. Committed to sustainability and corporate responsibility, Takeda emphasizes access to medicines, ethical practices, and transparency in governance. Through collaboration with diverse colleagues and a patient-centered approach, Takeda continues to advance science and technology to improve healthcare outcomes worldwide. Generated from the website

Acer Therapeutics Inc is a biopharmaceutical company based in Newton, MA. Specializing in the development and commercialization of innovative therapies for rare and life-threatening diseases, Acer Therapeutics Inc focuses on addressing unmet medical needs in niche patient populations. With a commitment to advancing scientific research and delivering impactful treatments, Acer Therapeutics Inc strives to make a meaningful difference in the lives of those affected by rare diseases. Through their dedication to improving patient outcomes, the company remains at the forefront of pioneering medical advancements. Generated from their business information